These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30053205)

  • 1. Molecular Regulation of Carcinogenesis: Friend and Foe.
    Patterson AD; Gonzalez FJ; Perdew GH; Peters JM
    Toxicol Sci; 2018 Oct; 165(2):277-283. PubMed ID: 30053205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic cancer chemoprevention on molecular targets during multistage carcinogenesis.
    Kim HS; Kacew S; Lee BM
    Arch Toxicol; 2016 Oct; 90(10):2389-404. PubMed ID: 27538406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms underlying curcumin-mediated microRNA regulation in carcinogenesis; Focused on gastrointestinal cancers.
    Akbari A; Sedaghat M; Heshmati J; Tabaeian SP; Dehghani S; Pizarro AB; Rostami Z; Agah S
    Biomed Pharmacother; 2021 Sep; 141():111849. PubMed ID: 34214729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.
    Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN
    Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between cancer and aging: a multilevel approach.
    Anisimov VN; Sikora E; Pawelec G
    Biogerontology; 2009 Aug; 10(4):323-38. PubMed ID: 19156531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants: friends or foe in prevention or treatment of cancer: the debate of the century.
    Saeidnia S; Abdollahi M
    Toxicol Appl Pharmacol; 2013 Aug; 271(1):49-63. PubMed ID: 23680455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Compounds: Role in Reversal of Epigenetic Changes.
    Aggarwal R; Jha M; Shrivastava A; Jha AK
    Biochemistry (Mosc); 2015 Aug; 80(8):972-89. PubMed ID: 26547065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic-Induced Carcinogenesis: The Impact of miRNA Dysregulation.
    Cardoso APF; Al-Eryani L; States JC
    Toxicol Sci; 2018 Oct; 165(2):284-290. PubMed ID: 29846715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds.
    Shanmugam MK; Lee JH; Chai EZ; Kanchi MM; Kar S; Arfuso F; Dharmarajan A; Kumar AP; Ramar PS; Looi CY; Mustafa MR; Tergaonkar V; Bishayee A; Ahn KS; Sethi G
    Semin Cancer Biol; 2016 Oct; 40-41():35-47. PubMed ID: 27038646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of ZEB1 in tumorigenic progression and epigenetic modifications.
    Zhang Y; Xu L; Li A; Han X
    Biomed Pharmacother; 2019 Feb; 110():400-408. PubMed ID: 30530042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy.
    Yarla NS; Bishayee A; Sethi G; Reddanna P; Kalle AM; Dhananjaya BL; Dowluru KS; Chintala R; Duddukuri GR
    Semin Cancer Biol; 2016 Oct; 40-41():48-81. PubMed ID: 26853158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
    Pratheeshkumar P; Son YO; Divya SP; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Wang Y; Shi X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):230-41. PubMed ID: 25448439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
    Cohen PA; Donini CF; Nguyen NT; Lincet H; Vendrell JA
    Oncotarget; 2015 Dec; 6(39):41566-81. PubMed ID: 26431164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular (de)regulation and cancer: new therapeutic strategies].
    Boulukos KE; Carlotti F; Pognonec P
    Bull Cancer; 2001 Apr; 88(4):363-8. PubMed ID: 11371370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classic and Novel Signaling Pathways Involved in Cancer: Targeting the NF-κB and Syk Signaling Pathways.
    Tang C; Zhu G
    Curr Stem Cell Res Ther; 2019; 14(3):219-225. PubMed ID: 30033874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red Beetroot and Betalains as Cancer Chemopreventative Agents.
    Lechner JF; Stoner GD
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31018549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of carcinogenesis by protease inhibitors.
    Kennedy AR
    Cancer Res; 1994 Apr; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Developmental Pathways: The Achilles Heel of Cancer?
    Dempke WCM; Fenchel K; Uciechowski P; Chevassut T
    Oncology; 2017; 93(4):213-223. PubMed ID: 28738360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.